Gary Wood hCG Body Shaper: Unapproved Drug Risk
Gary Wood's hCG Body Shaper product is unapproved by FDA due to contamination with human chorionic gonadotropin. Consumers should stop using it immediately as it may pose health risks.
Stop using this now
Marketed without an Approved NDA/ANDA; FDA analysis has found the product to be tainted with human chorionic gonadotropin, rendering it an unapproved drug
Contact the company
What happened, in plain English
Gary Wood's hCG Body Shaper product is recalled because it's marketed without FDA approval and contains human chorionic gonadotropin, making it an unapproved drug. This product could pose health risks if used. Read more at govinfonow.com/recall/41783-gary-wood-hcg-body-shaper-unapproved-drug-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/41783-gary-wood-hcg-body-shaper-unapproved-drug-risk · Updated October 8, 2026 · FDA enforcement record: FDA #D-0677-2017
Cite this page
“Gary Wood hCG Body Shaper: Unapproved Drug Risk.” GovInfoNow, updated October 8, 2026. https://govinfonow.com/recall/41783-gary-wood-hcg-body-shaper-unapproved-drug-risk. Based on FDA recall #D-0677-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0677-2017%22&limit=1).
Why it’s dangerous
The product is unapproved by the FDA and contains human chorionic gon:gonadotropin, which can cause health risks. It was marketed without proper regulatory approval and has been found to be contaminated with this substance.
Who’s affected
Anyone who purchased Gary Wood's hCG Body Shaper product. People using the product for body shaping or other purposes are at risk.
How to tell if you have this one
Look for the product name 'hCG Body Shaper' with 'Highly Purified Human Chorionic Gonadotrophin 5000 IU' on the label. The product is distributed by Gary Wood in St. Peters, MO and must be refrigerated.
- Brand
Gary Wood- Category
Drug
What to do — step by step
Stop Using It Now
The product is unapproved by the FDA and contains human chorionic gonadotropin, which can cause health risks.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2.1 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0677-2017 (March 28, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0677-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 8, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.